Characteristics | Patients | |
---|---|---|
n | (%) | |
Sex | ||
Female | 29 | (25) |
Male | 89 | (75) |
WHO performance status | ||
0 | 13 | (11) |
1 | 67 | (57) |
2 | 35 | (30) |
3 | 3 | (2) |
Tumor stagea | ||
2 | 37 | (31) |
3 | 71 | (60) |
4 | 10 | (9) |
Histological grade | ||
2 | 11 | (9) |
3 | 107 | (91) |
Clinical lymph node involvementb | ||
No | 109 | (92) |
Yes | 9 | (8) |
Hydronephrosis | ||
No | 97 | (82) |
Yes | 21 | (18) |
Tumor size | ||
2–4 cm | 37 | (31) |
4–6 cm | 58 | (49) |
≥6 cm | 22 | (19) |
Unknown | 1 | (1) |
Tumor resection status | ||
Not resected | 2 | (2) |
Complete resection | 13 | (11) |
Incomplete resection | 49 | (41) |
Unknown | 54 | (46) |
Planned radiotherapy dose | ||
55 Gy | 61 | (52) |
60 Gy | 57 | (48) |
Radiotherapy technique | ||
3D-conformal | 67 | (57) |
IMRT | 43 | (36) |
VMAT | 8 | (7) |
Focal simultaneous boost | ||
Concomitant | 101 | (86) |
Simultaneously integrated | 17 | (14) |
Treated with image-guidance | ||
No | 42 | (36) |
Yes | 76 | (64) |